Contra-indicated in patients with preexisting gallbladder disease.
- TRADE NAMES: Bolutol; Decrelip; Fibrocit; Gemlipid; Gen-Fibro; Gevilon Uno; Jezil; Lipur; Lopid (Pfizer); Nu-Gemfibrozil
- INDICATIONS: Hyperlipidemia
- CLASS: Fibrate, Lipid regulator
- HALF-LIFE: 2 hours
- CLINICALLY IMPORTANT, POTENTIALLY HAZARDOUS INTERACTIONS WITH:
Atorvastatin, Bexarotene, Colchicine, Cyclosporine, Dicumarol, Eluxadoline, Enzalutamide, Ezetimibe, Fluvastatin, Interferon Alfa, Lovastatin, Nicotinic acid, Ombitasvir/Paritaprevir/Ritonavir and Dasabuvir, Ozanimod, Paclitaxel, Pioglitazone, Pitavastatin, Pravastatin, Repaglinide, Rosiglitazone, Rosuvastatin, Roxithromycin, Selexipag, Simvastatin, Treprostinil, Tucatinib, Warfarin
- See adverse reactions attributed to class:
Please login to view the rest of this drug profile.
Page last updated 07/31/2023
